Ravidasvir (PPI-668, ASC16) is a potent second-generation, oral NS5A inhibitor for Hepatitis C virus research. It demonstrates high selectivity in vitro and has shown antiviral efficacy in clinical studies, making it a valuable tool for investigating HCV replication and treatment mechanisms.
Molekulargewicht:
835.828
CAS Nummer:
[1303533-81-4]
Formel:
C42H52Cl2N8O6
Target-Kategorie:
HCV Protease,Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten